AU3356000A - L-arginine based formulations for treating diseases and methods of using same - Google Patents
L-arginine based formulations for treating diseases and methods of using sameInfo
- Publication number
- AU3356000A AU3356000A AU33560/00A AU3356000A AU3356000A AU 3356000 A AU3356000 A AU 3356000A AU 33560/00 A AU33560/00 A AU 33560/00A AU 3356000 A AU3356000 A AU 3356000A AU 3356000 A AU3356000 A AU 3356000A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- same
- treating diseases
- based formulations
- arginine based
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 title 1
- 229930064664 L-arginine Natural products 0.000 title 1
- 235000014852 L-arginine Nutrition 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11890399P | 1999-02-05 | 1999-02-05 | |
| US60118903 | 1999-02-05 | ||
| PCT/US2000/002798 WO2000045809A1 (en) | 1999-02-05 | 2000-02-04 | L-arginine based formulations for treating diseases and methods of using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3356000A true AU3356000A (en) | 2000-08-25 |
Family
ID=22381443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU33560/00A Abandoned AU3356000A (en) | 1999-02-05 | 2000-02-04 | L-arginine based formulations for treating diseases and methods of using same |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1150669A4 (en) |
| JP (1) | JP2002536325A (en) |
| AU (1) | AU3356000A (en) |
| CA (1) | CA2361575A1 (en) |
| MX (1) | MXPA01007952A (en) |
| WO (1) | WO2000045809A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6425881B1 (en) * | 1994-10-05 | 2002-07-30 | Nitrosystems, Inc. | Therapeutic mixture useful in inhibiting lesion formation after vascular injury |
| US5968983A (en) | 1994-10-05 | 1999-10-19 | Nitrosystems, Inc | Method and formulation for treating vascular disease |
| CA2367002A1 (en) | 1999-03-19 | 2000-09-28 | Michael A. Moskowitz | Increasing cerebral bioavailability of drugs |
| JP5065570B2 (en) * | 2002-09-06 | 2012-11-07 | 第一三共ヘルスケア株式会社 | Vascular endothelial nitric oxide synthesis promoter |
| EP1663339B1 (en) * | 2003-08-14 | 2013-07-31 | Blue Medical Devices B.V. | Endoluminal prosthesis comprising a therapeutic agent |
| EP1591118A1 (en) * | 2004-04-27 | 2005-11-02 | Nutri-Fit GmbH & Co. KG | Use of melatonin in preventing postoperative complications |
| JP2012041296A (en) * | 2010-08-19 | 2012-03-01 | Medience Corp | Vascular endothelial function improving agent, nitric oxide production promoter, and food and drink |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4758569A (en) * | 1987-08-26 | 1988-07-19 | Pfizer Inc. | Doxazosin as an anti-atherosclerosis agent |
| US5270323A (en) * | 1990-05-31 | 1993-12-14 | Pfizer Inc. | Method of treating impotence |
| EP0667776A1 (en) * | 1992-11-04 | 1995-08-23 | Sepracor, Inc. | Methods and compositions of (+) doxazosin for the treatment of hypertension |
| ES2196027T3 (en) * | 1993-06-11 | 2003-12-16 | Univ Leland Stanford Junior | TREATMENT OF DEGENERATIVE VASCULAR DISEASES THROUGH MODULATION OF THE PRODUCTION OR ACTIVITY OF EXOGENOUS NITRICAL OXIDE. |
| US5543430A (en) * | 1994-10-05 | 1996-08-06 | Kaesemeyer; W. H. | Method and formulation of stimulating nitric oxide synthesis |
| DE69533584T2 (en) * | 1995-06-01 | 2005-02-17 | N.V. Nutricia | Clinical nutritional composition |
| FR2774593B1 (en) * | 1998-02-12 | 2000-05-05 | Philippe Gorny | OBTAINING A MEDICINE TO COMBAT FEMALE SEXUAL DYSFUNCTIONS |
| US6277884B1 (en) * | 1998-06-01 | 2001-08-21 | Nitromed, Inc. | Treatment of sexual dysfunction with N-hydroxyguanidine compounds |
-
2000
- 2000-02-04 WO PCT/US2000/002798 patent/WO2000045809A1/en not_active Ceased
- 2000-02-04 AU AU33560/00A patent/AU3356000A/en not_active Abandoned
- 2000-02-04 MX MXPA01007952A patent/MXPA01007952A/en unknown
- 2000-02-04 JP JP2000596929A patent/JP2002536325A/en active Pending
- 2000-02-04 CA CA002361575A patent/CA2361575A1/en not_active Abandoned
- 2000-02-04 EP EP00911701A patent/EP1150669A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1150669A1 (en) | 2001-11-07 |
| WO2000045809A1 (en) | 2000-08-10 |
| JP2002536325A (en) | 2002-10-29 |
| EP1150669A4 (en) | 2005-06-22 |
| MXPA01007952A (en) | 2004-03-26 |
| CA2361575A1 (en) | 2000-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
| AU7880700A (en) | Compositions and methods of treatment for skin conditions using extracts of turmeric | |
| AU2072201A (en) | Agents and methods for the treatment of proliferative diseases | |
| AU3998400A (en) | Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor | |
| AU2495200A (en) | Compositions and methods for the treatment of tumor | |
| AU2003200740A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200731A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200722A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2000260550A1 (en) | Treatment of skin damage using polyenylphosphatidylcholine | |
| AU7748000A (en) | Method and composition for the treatment of dermatologic diseases | |
| AU2212299A (en) | Compositions and methods for the treatment of tumor | |
| AUPQ415899A0 (en) | Compositions for and methods of treatment of allergic diseases | |
| AUPP968699A0 (en) | Therapeutic compositions and method for their preparation | |
| AU3632600A (en) | Compositions and methods for the treatment of immune related diseases | |
| AU9016898A (en) | Methods and compositions for treatment of restenosis | |
| AU3784999A (en) | Methods for treatment of pain | |
| AU9395998A (en) | Compositions and methods for the treatment of immune related diseases | |
| AU7061200A (en) | Compositions and method for treatment of acetaminophen intoxication | |
| AU3356000A (en) | L-arginine based formulations for treating diseases and methods of using same | |
| AU3434601A (en) | Compositions and methods for the treatment of immune related diseases | |
| AU2001234831A1 (en) | Magnetoliposome composition for targeted treatment of biological tissue and associated methods | |
| AU7653600A (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis | |
| AU2420101A (en) | Method and composition for the treatment of pain | |
| AU3996799A (en) | Alpha amino acid composition and method for the treatment of skin | |
| AU2566201A (en) | Compounds and methods for the treatment of pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |